|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Obesity Drug Markets in the US and EU
This report explores the dynamics and drivers of the market for current and emerging obesity treatments. This report evaluates the performances and attributes of currently marketed products and highlights the most effective strategies for securing fut
Anti-Obesity Treatments 2007-2012 - A blockbuster target market
Anti-Obesity Treatments 2007-2012, examines the market for anti-obesity drugs critically, through comprehensive primary and secondary research. In addition to consultation with experts in medical practice, academia and industry, this research involved
Digestive System - Acidity Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of acidity drugs by company and by stage as well as a summary of the latest news and developments in this area.
Pipeline Insight: Upper GI Disorders - Generics will limit...
Gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and peptic ulcer disease (PUD) represent a group of common gastrointestinal (GI) conditions, which can be referred to collectively as upper GI disorders. Gastric acid suppression remain
Forecast Insight: Antidiabetics
Competitive landscape analysis with threats to currently marketed drugs and recent changes in antidiabetics across seven major markets. Assessment of the opportunities available to novel agent classes, including DPP-IV inhibitors and GLP-1 agonists.
Pipeline Insight: Non-insulin antidiabetics 2008
Iincretin mimetics is to emerge as a major new therapeutic class in non-insulin antidiabetics, driven by an explosion in the patient population, safety fears surrounding established therapies and significant unmet patient needs.
Pipeline Insight: Osteoporosis
Analysis of disease-modifying drugs in late-stage clinical development for use in osteoporosis, including important clinical trial results, patient potential, market potential, and forecasts to 2016; supported by key opinion leader comments.
Stakeholder Insight: Diabetes
Type 2 diabetes is an emerging epidemic driven by the escalating prevalence of obesity and by an ageing population. Diagnosis rates will continue to increase as improved awareness raises the public profile of the disease. Despite several established c
Metabolic Endocrinology - Obesity Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of obesity drugs by company and by stage as well as a summary of the latest news and developments in this area.
Hemophilia or Blood Coagulation Disorders Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of hemophilia or blood coagulation disorders drugs by company and by stage as well as a summary of the latest news and developments in this area.
Insulin Delivery Systems Market Analysis (2007-2010)
The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their fut
Digestive System - Constipation Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of constipation drugs by company and by stage as well as a summary of the latest news and developments in this area.
|
